Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 20;15(1):139.
doi: 10.1186/s12920-022-01284-y.

Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review

Affiliations
Review

Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review

Cecilia Contreras-Cubas et al. BMC Med Genomics. .

Abstract

Background: Dysferlinopathy encompasses a group of rare muscular dystrophies caused by recessive mutations in the DYSF gene. The phenotype ranges from asymptomatic elevated serum creatine kinase (hyperCKemia) to selective and progressive involvement of the proximal and/or distal muscles of the limbs. Bohan and Peter criteria are the most widely used for the diagnosis of polymyositis, but they have limitations and can misclassify muscular dystrophies with inflammation as polymyositis. Most dysferlinopathy patients have muscle biopsies with inflammation and thus are vulnerable to misdiagnosis with polymyositis and inappropriate treatment with steroids and immunosuppressors.

Case presentation: We describe a 14 years-old male patient who was referred for assessment of asymptomatic hyperCKemia (26,372 IU/L). An X-linked dystrophinopathy initially was ruled out by direct genetic testing. Juvenile polymyositis was considered based on muscle biopsy, creatine kinase levels, and electromyography changes. Corticosteroid treatment triggered proximal lower limb muscular weakness, and no full muscular strength recovery was observed after corticosteroid withdrawal. Based on these observations, a limb-girdle muscular dystrophy (LGMD) was suspected, and LGMDR2 was confirmed by whole exome sequencing.

Conclusion: We report a dysferlinopathy patient who was misdiagnosed with juvenile polymyositis and explore in a literature review how common such misdiagnoses are. With diagnosis based only on routine clinicopathological examinations, distinguishing an inflammatory myopathy from dysferlinopathy is quite difficult. We suggest that before establishing a diagnosis of "definite" or "probable" juvenile polymyositis, according to Bohan and Peter or current ACR/EULAR criteria, a muscular dystrophy must first be ruled out.

Keywords: Case report; Dysferlinopathy; Limb-girdle muscular dystrophy; Polymyositis; Whole exome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Right quadriceps muscle biopsy. Representative microscopic images of hematoxylin and eosin (HE) staining. A HE 40x, perivascular lymphocytic infiltrates are observed (arrow). B HE 30x, variation in fiber size (stars), degeneration, and necrosis is noted (arrows). These images were obtained using the following equipment: microscope BX53 and camera DP73 (Olympus, Tokyo, Japan). Scanner Hamamatsu, Nanozoomer S210-NDP. View 2 version 2.9.29, was used as acquisition software and the measurement resolution was 1200dpi
Fig. 2
Fig. 2
A Family pedigree showing the c.3851C > T and c.5979dup mutation carriers. The patient and his mother carried the c.3851C > T variant, while the patient and his father the c.5979dup variant. B Nucleotide chromatograms of the affected region. Red arrows indicate the variants

References

    1. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, et al. Defective membrane repair in Dysferlin-deficient muscular dystrophy. Nature. 2003;423(6936):168–172. - PubMed
    1. Straub V, Murphy A, Udd B, LGMD Workshop Study Group 229th ENMC international workshop: limb girdle muscular dystrophies—nomenclature and reformed classification Naarden, the Netherlands. Neuromuscul Disord. 2018;28(8):702–710. - PubMed
    1. Nguyen K, Bassez G, Krahn M, Bernard R, Laforêt P, et al. Phenotypic study in 40 patients with Dysferlin gene mutations: high frequencyof atypical phenotypes. Arch Neurol. 2007;64(8):1176–1182. - PubMed
    1. Fanin M, Angelini C. Progress and challenges in diagnosis of dysferlinopathy. Muscle Nerve. 2016;54(5):821–835. - PubMed
    1. Huber AM. Juvenile idiopathic inflammatory myopathies. Pediatr Clin North Am. 2018;65(4):739–756. - PubMed

Supplementary concepts